High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins

Journal of Hematology and Oncology

Volumn 7, Issue 1, 2014, Pages

  Zheng, Xiaoyong ^a   Zhuge, Jian ^a   Bezerra, Stephania M ^b   Faraj, Sheila F ^b   Munari, Enrico ^b   Fallon, John T ^a   Yang, Ximing J ^c   Argani, Pedram ^b   Netto, George J ^b   Zhong, Minghao ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; TELOMERASE REVERSE TRANSCRIPTASE; TELOMERASE; TERT PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BLADDER SMALL CELL CARCINOMA; BREAST CARCINOMA; BREAST SMALL CELL CELL CARCINOMA; CERVICAL SMALL CELL CARCINOMA; CLINICAL ARTICLE; FEMALE; GASTROINTESTINAL CARCINOMA; GASTROINTESTINAL SMALL CELL CARCINOMA; GENE AMPLIFICATION; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; MALE; MERKEL CELL TUMOR; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROSTATE CARCINOMA; PROSTATE SMALL CELL CARCINOMA; SMALL CELL CARCINOMA; SMALL CELL LUNG CANCER; SOFT TISSUE CANCER; SOFT TISSUE SMALL CELL CARCINOMA; UTERINE CERVIX CARCINOMA; BLADDER TUMOR; GENETICS; MIDDLE AGED; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSITIONAL CELL CARCINOMA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BASE SEQUENCE; CARCINOMA, SMALL CELL; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TELOMERASE; URINARY BLADDER NEOPLASMS;

EID: 84905395516     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/s13045-014-0047-7     Document Type: Article

References (18)

1. Unusual and underappreciated: small cell carcinoma of the prostate. JS Palmgren, SS Karavadia, MR Wakefield, Semin Oncol 2007 34 22 29 10.1053/j.seminoncol.2006.10.026 17270662 (Pubitemid 46161758)
2. ERG gene rearrangements are common in prostatic small cell carcinomas. TL Lotan, NS Gupta, W Wang, A Toubaji, MC Haffner, A Chaux, JL Hicks, AK Meeker, CJ Bieberich, AM De Marzo, JI Epstein, GJ Netto, Mod Pathol 2011 24 820 828 10.1038/modpathol.2011.7 21336263
3. Telomerase RNA biosynthesis and processing. EM Smekalova, OS Shubernetskaya, MI Zvereva, EV Gromenko, MP Rubtsova, OA Dontsova, Biochemistry (Mosc) 2012 77 1120 1128 10.1134/S0006297912100045
4. TERT promoter mutations in familial and sporadic melanoma. S Horn, A Figl, PS Rachakonda, C Fischer, A Sucker, A Gast, S Kadel, I Moll, E Nagore, K Hemminki, D Schadendorf, R Kumar, Science 2013 339 959 961 10.1126/science. 1230062 23348503
5. Highly recurrent TERT promoter mutations in human melanoma. FW Huang, E Hodis, MJ Xu, GV Kryukov, L Chin, LA Garraway, Science 2013 339 957 959 10.1126/science.1229259 23348506
6. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. PJ Killela, ZJ Reitman, Y Jiao, C Bettegowda, N Agrawal, LA Diaz Jr, AH Friedman, H Friedman, GL Gallia, BC Giovanella, AP Grollman, TC He, Y He, RH Hruban, GI Jallo, N Mandahl, AK Meeker, F Mertens, GJ Netto, BA Rasheed, GJ Riggins, TA Rosenquist, M Schiffman, IM Shih, D Theodorescu, MS Torbenson, VE Velculescu, TL Wang, N Wentzensen, LD Wood, et al. Proc Natl Acad Sci U S A 2013 110 6021 6026 10.1073/pnas.1303607110 23530248
7. Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas. W Cheuk, MY Kwan, S Suster, JK Chan, Arch Pathol Lab Med 2001 125 228 231 11175640 (Pubitemid 32167475)
8. Large cell and small cell neuroendocrine bladder carcinoma: immunohistochemical and outcome study in a single institution. F Alijo Serrano, N Sanchez-Mora, J Angel Arranz, C Hernandez, E Alvarez-Fernandez, Am J Clin Pathol 2007 128 733 739 10.1309/HTREM6QYQDYGNWYA 17951193 (Pubitemid 350133982)
9. I Jonathan, Epstein GJN: Biopsy Interpretation of the Prostate. Fourth Edition edn Lippincott, Williams & Wilkins, Philadelphia 2008
10. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases. W Wang, JI Epstein, Am J Surg Pathol 2008 32 65 71 10.1097/PAS.0b013e318058a96b 18162772
11. Anthony di Sant'Agnese P: Small cell carcinoma of the prostate: an immunohistochemical study. JL Yao, R Madeb, P Bourne, J Lei, X Yang, S Tickoo, Z Liu, D Tan, L Cheng, F Hatem, J Huang, Am J Surg Pathol 2006 30 705 712 10.1097/00000478-200606000-00005 16723847 (Pubitemid 44264995)
12. Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma. L Cheng, TD Jones, RP McCarthy, JN Eble, M Wang, GT MacLennan, A Lopez-Beltran, XJ Yang, MO Koch, S Zhang, CX Pan, LA Baldridge, Am J Pathol 2005 166 1533 1539 10.1016/S0002- 9440(10)62369-3 15855652 (Pubitemid 40586521)
13. Insights from a whole cystectomy specimen-association of primary small cell carcinoma of the bladder with transitional cell carcinoma in situ. NT Gaisa, D Tilki, I Losen, E Dahl, R Stoehr, CG Stief, R Knuchel, Hum Pathol 2008 39 1258 1262 10.1016/j.humpath.2007.12.017 18547617
14. Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4. P Ramos, AN Karnezis, DW Craig, A Sekulic, ML Russell, WP Hendricks, JJ Corneveaux, MT Barrett, K Shumansky, Y Yang, SP Shah, LM Prentice, MA Marra, J Kiefer, VL Zismann, TA McEachron, B Salhia, J Prat, E D'Angelo, BA Clarke, JG Pressey, JH Farley, SP Anthony, RB Roden, HE Cunliffe, DG Huntsman, JM Trent, Nat Genet 2014 46 427 429 10.1038/ng.2928 24658001
15. Recurrent SMARCA4 mutations in small cell carcinoma of the ovary. P Jelinic, JJ Mueller, N Olvera, F Dao, SN Scott, R Shah, J Gao, N Schultz, M Gonen, RA Soslow, MF Berger, DA Levine, Nat Genet 2014 46 424 426 10.1038/ng.2922 24658004
16. Highly prevalent TERT promoter mutations in bladder cancer and glioblastoma. X Liu, G Wu, Y Shan, C Hartmann, A von Deimling, M Xing, Cell Cycle 2013 12 1637 1638 10.4161/cc.24662 23603989
17. Carrillo-de Santa Pau E, Masius RG, Kogevinas M, Steyerberg EW, van Tilborg AA, Abas C, Orntoft TF, Zuiverloon TC, Malats N, Zwarthoff EC, Real FX: Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome. Y Allory, W Beukers, A Sagrera, M Flandez, M Marques, M Marquez, KA van der Keur, L Dyrskjot, I Lurkin, M Vermeij, A Carrato, J Lloreta, JA Lorente, Eur Urol 2014 65 360 366 10.1016/j.eururo.2013.08.052 24018021
18. TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine. I Kinde, E Munari, SF Faraj, RH Hruban, M Schoenberg, T Bivalacqua, M Allaf, S Springer, Y Wang, LA Diaz Jr, KW Kinzler, B Vogelstein, N Papadopoulos, GJ Netto, Cancer Res 2013 73 7162 7167 10.1158/0008-5472.CAN-13-2498 24121487